PGNX..$5.61..watching here as I like this pullback as well as the risk/reward in this stock.
Participants in Open-label Treatment Extension of PSMA ADC, with results due ASCO Jan http://t.co/WVgOUirDkm. You also have the ADCOM Meeting in March. Will be a packed Q1/2014 for this stock.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.